乳腺癌患者综合治疗的疗效及预后分析(3)
 |
| 第1页 |
参见附件(3029KB，3页)。
综上所述，原发肿瘤大小、腋窝淋巴结转移情况及TNM分期是影响预后的重要的独立因素，需重视体检，能尽量早期发现、早期治疗，这才是解决问题、提高生存率的关键。
[参考文献]
[1] Chow LW, Loo WT. The differential effects of cyclophosphamide, ep irubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein [p21(WAF-1)] and anti-apoptotic protein (bcl-2) in breast cancer cells [J]. Breast Cancer Res Treat,2003,80(3):239-244.
[2] Jacobs JR, Bovasso GB. Early and chronic stress and their relation to breast cancer [J]. Psychol Med,2000,30(3):669-678.
[3] Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology [J]. J Clin Oncol,2001,19(5):1539-1569.
[4] Han W, Kang SY. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer [J]. Breast Cancer Res Treat,2010,119(1):193-200.
[5] Khanfir A, Frikha M, Kallel F, et al. Breast cancer in young women in the south of Tunisia [J]. Cancer Radiother,2006,10(8):565-571.
[6] 沈恩超,王水,凌立君,等.芳香化酶抑制剂在乳腺癌内分泌治疗中的研究进展[J].江苏大学学报:医学版,2006,16(5):456-458.
[7] 沈镇宙,邵志敏.乳腺肿瘤学[M].上海:上海科学技术出版社,2005:302.
(收稿日期：2011-02-28)
[作者简介]沈伟娟(1979-)，女，江苏常州人，主治医师。
您现在查看是摘要介绍页，详见PDF附件(3029KB，3页)。